Novocure (NASDAQ: NVCR) announced that Anthem, Inc. now covers Optune for members who have newly diagnosed glioblastoma (GBM). Anthem, the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE